⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda® (Pembrolizumab), in the U.S. and Canada
globenewswire.com
MRK
Senior Pharma and Biotech Leaders to Convene for Industry Forum at San Francisco CEO Ahead of JP Morgan Healthcare Conference
accessnewswire.com
JPM
JNJ
AMGN
MRK
BMY
REGN
Strategic Pharma Collaborations Propel RCC Market Growth
globenewswire.com
MRK
AZN
PFE
EXEL
BioNxt treibt „Melt in Your Mouth“-Cladribin-Formulierung voran, um die Behandlung von MS-Patienten mit Dysphagie zu verbessern
accessnewswire.com
MRK
Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
AMGN
PFE
LLY
AZN
BMY
NVS
SNY
GSK
UCB
ARQT
REGN
INCY
ABBV
BIIB
MRK
JNJ
VNDA
RAPT
CHAI
ONON
ION
ASMB
CRVS
APG
KSCP
KYMR
XBI
IBB
ADSK
CDNS
SNPS
TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxembourg
newsfilecorp.com
MRK
Merck Sharp & Dohme LLC Data Breach Under Investigation by Levi & Korsinsky, LLP
accessnewswire.com
MRK
Peptide Synthesis Reagents Research Report 2025: $1.5 Bn Market Opportunities, Growth Drivers, Industry Trend Analysis, and Forecasts 2024-2034
globenewswire.com
TMO
MRK
Immunotherapy Drugs Research Report 2025: $526.5 Bn Market Opportunities, Growth Drivers, Industry Trend Analysis, and Forecast 2024-2034
globenewswire.com
AMGN
PFE
JNJ
BMY
GILD
MRK
MDT
ADAP
Companion Diagnostics Market Research 2025: $21+ Bn Opportunities, Growth Drivers, Industry Trend Analysis, and Forecasts 2024-2034
globenewswire.com
PFE
MRK
AZN
TMO
ABT
AMGN
JNJ
BMY
LLY
MYGN
GRDX
BIIB
BDX